CAPTRUST Financial Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.17M | Buy |
|
|||||
|
2025
Q1 | $1.6M | Buy |
|
|||||
|
2024
Q4 | $940K | Buy |
|
|||||
|
2024
Q3 | $766K | Buy |
|
|||||
|
2024
Q2 | $669K | Buy |
|
|||||
|
2024
Q1 | $511K | Sell |
|
|||||
|
2023
Q4 | $706K | Sell |
|
|||||
|
2023
Q3 | $675K | Buy |
|
|||||
|
2023
Q2 | $492K | Buy |
|
|||||
|
2023
Q1 | $465K | Buy |
|
|||||
|
2022
Q4 | $348K | Buy |
|
|||||
|
2022
Q3 | $265K | Buy |
|
|||||
|
2022
Q2 | $257K | Sell |
|
|||||
|
2022
Q1 | $252K | Sell |
|
|||||
|
2021
Q4 | $330K | Buy |
|
|||||
|
2021
Q3 | $268K | Sell |
|
|||||
|
2021
Q2 | $307K | Buy |
|
|||||
|
2021
Q1 | $255K | Buy |
|
|||||
|
2020
Q4 | $290K | Sell |
|
|||||
|
2020
Q3 | $283K | Sell |
|
|||||
|
2020
Q2 | $541K | Sell |
|
|||||
|
2020
Q1 | $376K | Buy |
|
|||||
|
2019
Q4 | $359K | Buy |
|
|||||
|
2019
Q3 | $201K | Hold |
|
|||||
|
2019
Q2 | $256K | Sell |
|
|||||
|
2019
Q1 | $285K | Sell |
|
|||||
|
2018
Q4 | $299K | Buy |
|
|||||
|
2018
Q3 | $316K | Buy |
|